Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses ORIC in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ORIC in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Jacob Chacko | $657,500 | $0 | $826,000 | $3,634,560 | $434,000 | $0 | $15,104 | $5,567,164 |
| President, Chief Executive Officer and Director | ||||||||
| Pratik Multani | 513,333 | 0 | 280,840 | 1,226,664 | 246,500 | 0 | 15,104 | 2,282,441 |
| Chief Medical Officer | ||||||||
| Dominic Piscitelli | 482,917 | 0 | 280,840 | 1,226,664 | 231,900 | 0 | 15,104 | 2,237,425 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Jacob Chacko | $5,567,164 | — | — | — |
| Pratik Multani | 2,282,441 | — | — | — |
| Dominic Piscitelli | 2,237,425 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Richard A. Heyman | Director | 2026-07-06 | D | 300 | $12 | $3,600 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | A | 3,500 | 2 | 5,600 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | D | 6,100 | 12 | 73,322 | Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | D | 3,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Richard A. Heyman | Director | 2026-07-24 | D | 7,000 | 12 | 84,140 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Jacob Chacko | PSU | — | — | — | — | — | $826,000 |
| Jacob Chacko | OPTION | — | — | — | — | — | 3,634,560 |
| Dominic Piscitelli | OPTION | — | — | — | — | — | 1,226,664 |
| Pratik Multani | OPTION | — | — | — | — | — | 1,226,664 |
| Dominic Piscitelli | PSU | — | — | — | — | — | 280,840 |
| Pratik Multani | PSU | — | — | — | — | — | 280,840 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Jacob Chacko | $0 | $826,000 | $3,634,560 | 18.5% |
| Dominic Piscitelli | 0 | 280,840 | 1,226,664 | 18.6% |
| Pratik Multani | 0 | 280,840 | 1,226,664 | 18.6% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Pratik Multani | RSU | 22,667 | — | $185,416 |
| Pratik Multani | Option | 93,750 | 9.14 | — |
| Pratik Multani | RSU | 10,000 | — | 81,800 |
| Pratik Multani | Option | 28,985 | 4.36 | — |
| Jacob Chacko | Option | 600,000 | 8.26 | — |
| Dominic Piscitelli | Option | 93,750 | 9.14 | — |
| Pratik Multani | Option | 202,500 | 8.26 | — |
| Jacob Chacko | Option | 84,584 | 4.36 | — |
| Jacob Chacko | Option | 850,500 | 1.6 | — |
| Jacob Chacko | Option | 437,500 | 4.36 | — |
| Pratik Multani | Option | 231,250 | 1.6 | — |
| Jacob Chacko | RSU | 66,667 | — | 545,336 |
| Pratik Multani | Option | 147,500 | 4.36 | — |
| Jacob Chacko | RSU | 28,334 | — | 231,772 |
| Dominic Piscitelli | Option | 28,985 | 4.36 | — |
| Jacob Chacko | Option | 265,625 | 9.14 | — |
| Jacob Chacko | Option | 116,667 | 6 | — |
| Dominic Piscitelli | RSU | 22,667 | — | 185,416 |
| Dominic Piscitelli | RSU | 10,000 | — | 81,800 |
| Dominic Piscitelli | Option | 42,292 | 6 | — |
| Pratik Multani | Option | 42,292 | 6 | — |
| Dominic Piscitelli | Option | 202,500 | 8.26 | — |
| Dominic Piscitelli | Option | 282,750 | 4.36 | — |
Base salary is set at a level that is commensurate with the named executive officer's duties and authorities, contributions, prior experience and sustained performance. We design our employee benefits programs to be affordable and competitive in relation to the market, as well as compliant with applicable laws and practices.
| CEO STI target (% of salary) | 55% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-18 | 88,453,809 | 1,250,074 | 2,373 | 98.6% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-18 | 98.6%a |
a. Approved under the standard stated in the filing — “As a result, abstentions will be counted for purposes of determining the presence or absence of a quorum and will also count as votes against a proposal in cases where approval of the proposal requires the affirmative vote of a majority of the voting power of the shares present in person (virtually) or represented by proxy at the Annual Meeting and entitled to vote on the subject matter ( e.g.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Richard Heyman, Ph.DIndependent · Board Chair · Compensation (Chair) · Nominating/Governance (Chair) | $100,000 | $0 | $206,021 | $0 | $0 | $306,021 |
| Mardi C. DierIndependent · Audit (Chair) · Nominating/Governance | 60,000 | 0 | 206,021 | 0 | 0 | 266,021 |
| Angie You, Ph.DIndependent · Audit · Nominating/Governance | 52,500 | 0 | 206,021 | 0 | 0 | 258,521 |
| Steven L. HoerterIndependent · Audit · Compensation | 52,500 | 0 | 206,021 | 0 | 0 | 258,521 |
| Lori Kunkel, M.DIndependent · Compensation | 45,000 | 0 | 206,021 | 0 | 0 | 251,021 |
| Jacob M. Chacko, M.DEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 20,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $310,000 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $310,000 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Oric Pharmaceuticals | 2025 | Jacob Chacko | $657,500 | $826,000 | $3,634,560 | $434,000 | $5,567,164 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Jacob Chacko | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Summary Compensation Table” · page 42. As printed: 5,567,164. Filing ↗machine: r2 · c26 · span 435191–435200 |
| 2 | Section 01, Pratik Multani | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Summary Compensation Table” · page 42. As printed: 2,282,441. Filing ↗machine: r6 · c26 · span 444560–444569 |
| 3 | Section 01, Dominic Piscitelli | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Summary Compensation Table” · page 42. As printed: 2,237,425. Filing ↗machine: r4 · c26 · span 439892–439901 |
| 4 | Section 03, Jacob Chacko PSU | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t126 · r2 · c15 · span 397337–397344 |
| 5 | Section 03, Jacob Chacko OPTION | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t132 · r2 · c15 · span 434198–434207 |
| 6 | Section 03, Dominic Piscitelli OPTION | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t132 · r4 · c15 · span 438899–438908 |
| 7 | Section 03, Pratik Multani OPTION | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Summary Compensation Table” · grants of plan-based awards table. Filing ↗machine: t132 · r6 · c15 · span 443567–443576 |
| 8 | Section 03, Dominic Piscitelli PSU | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t126 · r4 · c15 · span 399246–399253 |
| 9 | Section 03, Pratik Multani PSU | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t126 · r6 · c15 · span 401137–401144 |
| 10 | Section 07, pay ratio | 10-K | 2026-02-23 | 0001193125-26-064005 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 11 | Section 08, Richard Heyman, Ph.D | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Director Compensation”. As printed: 306,021. Filing ↗machine: t81 · r2 · c11 · span 251091–251098 |
| 12 | Section 08, Mardi C. Dier | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Director Compensation”. As printed: 266,021. Filing ↗machine: t81 · r3 · c11 · span 252217–252224 |
| 13 | Section 08, Angie You, Ph.D | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Director Compensation”. As printed: 258,521. Filing ↗machine: t81 · r6 · c11 · span 255656–255663 |
| 14 | Section 08, Steven L. Hoerter | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Director Compensation”. As printed: 258,521. Filing ↗machine: t81 · r4 · c11 · span 253372–253379 |
| 15 | Section 08, Lori Kunkel, M.D | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Director Compensation”. As printed: 251,021. Filing ↗machine: t81 · r5 · c11 · span 254502–254509 |
| 16 | Section 08, Jacob M. Chacko, M.D | DEF 14A | 2026-04-28 | 0001193125-26-186911 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 17 | Section 02, Richard A. Heyman 2026-07-06 | Form 4 | 2026-07-08 | 0001584759-26-000012 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 18 | Section 02, Richard A. Heyman 2026-07-24 | Form 4 | 2026-07-28 | 0001584759-26-000015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 19 | Section 02, Richard A. Heyman 2026-07-24 | Form 4 | 2026-07-28 | 0001584759-26-000015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 20 | Section 02, Richard A. Heyman 2026-07-24 | Form 4 | 2026-07-28 | 0001584759-26-000015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 21 | Section 02, Richard A. Heyman 2026-07-24 | Form 4 | 2026-07-28 | 0001584759-26-000015 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 22 | Section 06, 2026 vote | Form 8-K | 2026-06-22 | 0001193125-26-277511 | Item 5.07 · say-on-pay result. As reported: 98.6% (votes for as printed: 88,453,809). Filing ↗ |
| 23 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 24 | Section 09b board cost (computed) | Computed | — | computed | Cash 310,000 + equity 0 + all other 0 = 310,000, summed across the director compensation table rows.machine: formula: Σ = 310,000 |
| 25 | Oric Pharmaceuticals (subject), Section 10b CEO total | DEF 14A | 2026-04-28 | 0001193125-26-186911 | CEO total compensation as printed in Oric Pharmaceuticals's own proxy. As printed: 5,567,164. Filing ↗machine: r2 · c26 · span 435191–435200 |